Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. - Wikidata - awgldk - TriplyDB

Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.

Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.

http://www.wikidata.org/entity/Q34828549

about

Monocytes in atherosclerosis: subsets and functions An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin.Regulation of atherogenesis by chemokines and chemokine receptors Heterogeneity of lung mononuclear phagocytes in chronic obstructive pulmonary disease Role of CX3CR1 receptor in monocyte/macrophage driven neovascularization Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression Thrombin and vascular inflammation Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications Interleukin-15 inhibits smooth muscle cell proliferation and hyaluronan production in rat ductus arteriosus Greater fractalkine expression in mesenteric arteries of female spontaneously hypertensive rats compared with males Monocyte recruitment during infection and inflammation Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors Genome-wide microarray analyses identify the protein C receptor as a novel calcineurin/nuclear factor of activated T cells-dependent gene in vascular smooth muscle cell phenotypic modulation.Syk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages.Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation Cyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway.Genetic variants in platelet factor 4 modulate inflammatory and platelet activation biomarkers.Cytoskeletal confinement of CX3CL1 limits its susceptibility to proteolytic cleavage by ADAM10 Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells.CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration.Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility.Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR study CX3CR1 deficiency does not influence trafficking of adipose tissue macrophages in mice with diet-induced obesity.Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root.The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcome Innate and adaptive immunity in atherosclerosis.Fractalkine (CX3CL1), GM-CSF and VEGF-a levels are reduced by statins in adult patients.Chemokines and angiogenesis in rheumatoid arthritis.Monocytes: protagonists of infarct inflammation and repair after myocardial infarction Chemokines and chemokine receptors in arthritis.Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysis CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice.Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice Role of fractalkine/CX3CR1 interaction in light-induced photoreceptor degeneration through regulating retinal microglial activation and migration Neferine inhibits angiotensin II-induced rat aortic smooth muscle cell proliferation predominantly by downregulating fractalkine gene expression Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.

P2860

Q22251045-3881EED1-BED5-4D44-8BCB-1B08FA403559 Q24300694-41400486-05AE-4593-925F-2061FA1B8917 Q24814510-2207F5C2-61BD-45A3-B389-DA3B46C3DA58 Q27003124-D7DE3E07-A148-4E4C-A81D-228C31933A4E Q27014453-645542D1-98C5-4DF2-803D-A08585D4F358 Q27313463-0A5BB1CA-76E1-41A9-A355-74B13356BFA8 Q27332432-660B3AD1-638C-45D7-BE5C-882FCAD340DB Q28246124-F3E98FAD-DD41-4850-A1F0-051F3B64E902 Q28275105-C4B271BD-72CA-4C75-A8E1-F27960229AAA Q28275259-454A2235-67A6-4ADE-944B-FF597B8339A4 Q28567965-38C9EB7C-FA3C-4AC7-96B3-60F6D4BAB782 Q28571899-53DAAA9B-1C21-417E-A36E-9A3AAC8F0E98 Q29620067-2CB88440-5F2E-4A5F-BBDF-98CAA36694EE Q30318502-C6E8ABEB-AE1C-488C-8418-87156F24E0D1 Q30319434-78A98955-2799-4B4D-89FB-554E66C95D0B Q30409523-3AA2CE37-8DDF-4DB0-A249-05B649758ED8 Q30424180-1FAB8FD5-6B25-43BC-A7DA-EB93072A4932 Q30427232-11EB6209-741C-4C04-84DA-64949EED40AF Q30433016-0A2AF9ED-8157-46C8-BC85-24A4554341FA Q30491848-A90AFDD5-A1EA-4623-A31D-9FDA9373A77D Q30559534-428D864F-F017-4620-A81D-125216DBF5EA Q30601949-6B67D77E-83A3-4201-986C-D21F5837F98A Q30829602-AEBA63E3-1031-44DD-9CF3-0C300E127D8E Q33301145-B1089234-5BA3-4A18-89C4-28AA9727FFBB Q33410786-BA461CB3-44E1-4FFA-BF4D-F20D5DAD5D0C Q33479988-68B90636-24CE-4377-A9BF-6F5672AE543B Q33554073-0C4592A1-08F2-4F3D-92E1-CB6AB8D63BBF Q33580505-0FDA84F1-116D-4CF1-AA59-4F2A93F2651B Q33615950-2B79A860-0BA3-4006-94D1-5F824B39CDB9 Q33659705-FB9C4F18-52D9-48B6-8F95-941F04687D69 Q33794941-8C3207CB-6D1D-4634-A38A-E2F774B6EE16 Q33909030-EAC33905-9F72-42B1-9AA5-931668D507A2 Q33942337-65A0F7A7-403C-4E9A-A2C0-6A1ADA739B44 Q34051768-4A0080A7-C439-49BA-9A73-E99EDA7EA8CB Q34152811-4D620BFD-0C1D-4F36-9CFC-56B2DB104CC6 Q34163933-C2B91088-161E-4CC6-A660-B94D91B03B5C Q34236802-B134928F-F154-494F-9D40-0AAADACE5393 Q34247267-96FFDECF-1928-4659-86FF-9BEEEEBAB664 Q34292590-E24F67C3-55FA-41FA-A4A6-34B50D4CB194 Q34391705-E9C5ADAE-96B9-4BAA-AC68-42DCDF03EDE1

P2860

Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.

http://www.wikidata.org/entity/Q34828549

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Decreased atherosclerosis in C ...... fractalkine in atherogenesis.

@ast

Decreased atherosclerosis in C ...... fractalkine in atherogenesis.

@en

Decreased atherosclerosis in C ...... fractalkine in atherogenesis.

@nl

type

label

Decreased atherosclerosis in C ...... fractalkine in atherogenesis.

@ast

Decreased atherosclerosis in C ...... fractalkine in atherogenesis.

@en

Decreased atherosclerosis in C ...... fractalkine in atherogenesis.

@nl

prefLabel

Decreased atherosclerosis in C ...... fractalkine in atherogenesis.

@ast

Decreased atherosclerosis in C ...... fractalkine in atherogenesis.

@en

Decreased atherosclerosis in C ...... fractalkine in atherogenesis.

@nl

P1433

Q34828549-C74F29A3-ED3D-4924-86A1-E22481A26D55

P1476

Q34828549-3F97812C-CD88-4530-8B85-7ECDE00AC43B

P2093

Q34828549-36CD86D4-A91F-4F8C-B302-184B2CE30BBB

Q34828549-7C22A992-BF76-413B-9EB6-CCF43717D580

Q34828549-CE45F70F-A19A-401A-B79B-C23B6E6788F5

P2860

Q34828549-01081A5B-CF46-4C43-9EAC-009C7A368587

Q34828549-088C2BD7-75B7-4852-9DE2-8C924D3A75BC

Q34828549-268CF528-0DCE-43EC-B668-7AC40D825B4C

Q34828549-276B834E-9FE7-43F3-928B-943C70C4B0C2

Q34828549-3C69212C-611C-4A9E-8CFE-C8D5093EE9C0

Q34828549-44EE3CF2-43E4-4198-9B06-5F7036838156

Q34828549-5FC3263E-6833-4DC0-B235-03D249473468

Q34828549-69F6C6EC-8E79-46EF-ABA7-856CA0076491

Q34828549-6ED9EFDE-25BB-413B-A6A0-EDA7D1360572

Q34828549-702701E2-F2BF-4E98-A6C7-185CC91AB8C8

P304

Q34828549-F55C8F4D-2F13-41ED-AD94-C2F1BBE672F2

P31

Q34828549-ADCC60D9-E0FC-4146-99BB-4FA39E6ED4C2

P356

Q34828549-3986113A-FE57-4ADB-AB08-771EE1AB631C

P407

Q34828549-D851058A-1ECE-4A21-A8F6-FBA9C6131366

P433

Q34828549-1B813DB6-29B7-439F-BA7A-EF61BB9A68C8

P478

Q34828549-549548C3-0392-47C3-BE31-44D6A37CB10F

P577

Q34828549-67C14E56-CFC4-49FF-A8D2-221C8A03CD1E

P698

Q34828549-93DE9508-EB6E-470C-8EFF-67C5DE1BBEB7

P921

Q34828549-2D278B05-1B8A-4D20-9A7A-3E27A0B83407

P932

Q34828549-C9A4FD65-B78A-4E02-A1E7-CF2F48C13660

P356

P1433

Journal of Clinical Investigation

P1476

Decreased atherosclerosis in C ...... fractalkine in atherogenesis.

@en

P2093

Christopher A Haskell

http://www.w3.org/2001/XMLSchema#string

Israel F Charo

http://www.w3.org/2001/XMLSchema#string

Philippe Lesnik

http://www.w3.org/2001/XMLSchema#string

P2860

Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease

Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation

A new class of membrane-bound chemokine with a CX3C motif

Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS

Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia

P304

333-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI15555

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12569158

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

151849

http://www.w3.org/2001/XMLSchema#string